NASDAQ : DRMA
Dermata Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.775 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Details
| Name | Dermata Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 9 |
| Founded | 2014 |
| Ipo Date | 2021-08-13 |
| Ceo | Gerald Proehl |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 7.00 |
| Isin | US2498455045 |
| Cusip | 249845504 |
| Cik | 1853816 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Gerald T. Proehl | Founder, President, Chief Executive Officer and Chairman |
| David F. Hale | Co-Founder and Lead Independent Director |
| Kyri K. Van Hoose CPA, M.B.A. | Senior Vice President and Chief Financial Officer |
| Dr. Christopher J. Nardo M.P.H., Ph.D. | Senior Vice President and Chief Development Officer |
| Sean Proehl | Associate General Counsel |
| Kyra Peckaitis | Vice President of Marketing |
| Dr. Maria Bedoya Toro Munera M.B.A., Ph.D. | Senior Vice President of Regulatory Affairs and Quality Assurance |
Contact
| Address | 3525 Del Mar Heights Rd., Suite 332, San Diego, California 92130, United States |
| Phone | 858 800 2543 |
| Website | https://www.dermatarx.com |